ESC 365 - MicroRNA 18a is a novel regulator of reverse cholesterol transport and potential therapeutic targets in atherosclerosis

ESC Premium Access

MicroRNA 18a is a novel regulator of reverse cholesterol transport and potential therapeutic targets in atherosclerosis

Session: Poster session 7 - Genetics and gene therapy

Topic: Metabolism and metabolic syndromes

Speaker: Assistant Professor T. Kim (Seoul, KR)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Assistant Professor Tae-Hoon Kim

Seoul (Korea (Republic of))

0 follower

5 more presentations in this session

MicroRNA profiles in patients with cardiac amyloidosis and dilated cardiomyopathy - A preliminary epigenetic approach

Speaker: Doctor S. Becker (Stuttgart, DE)

GENomE wide analysis of Sotalol-induced IKr inhibition : lack of common variants with large effect sizes.

Speaker: Professor J. Hulot (Paris, FR)

VEGF-B cardiac gene therapy with differential expression using the anf-promoter or therapy delay during heart failure development in a pre-clinical model of dilated cardiomyopathy.

Speaker: Doctor F. Woitek (Leipzig, DE)

BACE1-AS long noncoding RNA and beta-amyloid involvement in ischemic heart failure patients

Speaker: Doctor S. Greco (San Donato Milanese, IT)

Brown adipose tissue dysfunction has a pathological role for the progression of cardiac metabolic remodeling in heart failure

Speaker: Doctor Y. Yoshida (Tokyo, JP)

Access the full session

Poster session 7 - Genetics and gene therapy

Speakers: Assistant Professor T. Kim, Doctor S. Becker, Professor J. Hulot, Doctor F. Woitek, Doctor S. Greco...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources